AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

NCT04099966 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Acute Leukemia
Severe Aplastic Anemia
Non-hodgkin Lymphoma
Hodgkin Lymphoma
Kostmann
Diamond Blackfan Anemia
Amegakaryocytic Thrombocytopenia
Sickle Cell Disease
Beta-Thalassemia

Interventions

DRUG: alpha beta depletion

Sponsor

Mitchell Cairo